A newly published article in the Journal of Clinical Oncology reports data from a small, randomized, multicenter, Phase II clinical trial comparing active monitoring to treatment of men with recurrent, asymptomatic, oligometastatic prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: MDT, metastasis-directed, monitoring, oligometastasis, oligorecurrent, surveillance, Treatment | 16 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 